Niaid preclinical development support - immunoaffinity purification of HIV-1 envelope trimer proteins
Ended Awarded Last action
- Contract number
- HHSN27200033
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,816,780
Award facts
- Contract value 100% obligated
- $3,816,780.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$78,903 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,895,683 |
About this award
This federal contract award is for NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENVELOPE TRIMER PROTEINS, with a ceiling value of $3,816,780.25. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods specializing in the development of vaccines, therapeutics, and diagnostics. The contract is a delivery order under the NIAID PRECLINICAL DEVELOPMENT SUPPORT - PERFORMANCE OF TOXICITY TESTING FOR HIV PROTEINS program. ABL has been awarded several Indefinite Delivery Vehicles (IDVs) with the National Institutes of Health (NIH), including the Diagnostics Pre-Clinical Services Program, Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders, and the PREVENT Cancer Preclinical Drug Development Program. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN27200033?
HHSN27200033 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 9, 2016.
How much is contract HHSN27200033 worth?
The government has obligated $3,816,780 on HHSN27200033.
Is contract HHSN27200033 an order under another contract?
Yes. HHSN27200033 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200033 competed?
The extent of competition for HHSN27200033 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award